DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
40 hedge funds and large institutions have $2.73M invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
40
Holding in Top 10
–
Calls
$89K
Puts
–
Top Buyers
| 1 | +$59.6K | |
| 2 | +$44.4K | |
| 3 | +$28.7K | |
| 4 |
VF
Virtu Financial
New York
|
+$2K |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$1.3K |
Top Sellers
| 1 | -$50K | |
| 2 | -$42K | |
| 3 | -$34K | |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
-$11K |
| 5 |
CAC
Cowen and Company
New York
|
-$10.9K |